Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis.
about
Porcine circovirus type 2 in China: an update on and insights to its prevalence and controlPorcine circovirus: a historical perspectiveDevelopment of a surface plasmon resonance biosensing approach for the rapid detection of porcine circovirus type2 in sample solutionsA cucumber mosaic virus based expression system for the production of porcine circovirus specific vaccines.Reliability of operational data from pig herds and performance ratings by veterinarians and pig farmers collected during telephone interviews for the evaluation of a PCV2 piglet vaccination.Circovirus in tissues of dogs with vasculitis and hemorrhage.Peptides mimicking viral proteins of porcine circovirus type 2 were profiled by the spectrum of mouse anti-PCV2 antibodiesComplex links between natural tuberculosis and porcine circovirus type 2 infection in wild boar.Influence of porcine circovirus type 2 vaccination on the probability and severity of pneumonia detected postmortem.PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection.T-cell reprogramming through targeted CD4-coreceptor and T-cell receptor expression on maturing thymocytes by latent Circoviridae family member porcine circovirus type 2 cell infections in the thymus.Genomic characterization of a circovirus associated with fatal hemorrhagic enteritis in dog, Italy.Evaluation of the capability of the PCV2 genome to encode miRNAs: lack of viral miRNA expression in an experimental infection.Identification of microRNAs in PCV2 subclinically infected pigs by high throughput sequencing.Identification of Putative ORF5 Protein of Porcine Circovirus Type 2 and Functional Analysis of GFP-Fused ORF5 ProteinComparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China.Revisiting the taxonomical classification of Porcine Circovirus type 2 (PCV2): still a real challengeImpact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different ageHigh detection rate of dog circovirus in diarrheal dogsViral Metagenomic Analysis Displays the Co-Infection Situation in Healthy and PMWS Affected Pigs.Nitric oxide-generating compound GSNO suppresses porcine circovirus type 2 infection in vitro and in vivo.A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.Cost of post-weaning multi-systemic wasting syndrome and porcine circovirus type-2 subclinical infection in England - an economic disease model.Economic efficiency analysis of different strategies to control post-weaning multi-systemic wasting syndrome and porcine circovirus type 2 subclinical infection in 3-weekly batch system farms.Effect of sow vaccination against porcine circovirus type 2 (PCV2) on virological profiles in herds with or without PCV2 systemic diseaseOverexpression of pig selenoprotein S blocks OTA-induced promotion of PCV2 replication by inhibiting oxidative stress and p38 phosphorylation in PK15 cellsEvaluation of natural porcine circovirus type 2 (PCV2) subclinical infection and seroconversion dynamics in piglets vaccinated at different ages.A Novel Porcine Circovirus Distantly Related to Known Circoviruses Is Associated with Porcine Dermatitis and Nephropathy Syndrome and Reproductive FailureSerologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis.Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.Global Status of Porcine circovirus Type 2 and Its Associated Diseases in Sub-Saharan Africa.Memory T cell proliferative responses and IFN-γ productivity sustain long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease.Best practice and future challenges for vaccination against porcine circovirus type 2.Porcine Circovirus 2 Deploys PERK Pathway and GRP78 for Its Enhanced Replication in PK-15 Cells.Porcine circovirus 2 (PCV2) increases the expression of endothelial adhesion/junction moleculesInteractions of porcine circovirus 2 with its hosts.Secreted expression of truncated capsid protein from porcine circovirus type 2 in Pichia pastoris.Pigs naturally exposed to porcine circovirus type 2 (PCV2) generate antibody responses capable to neutralise PCV2 isolates of different genotypes and geographic origins.Depletion of follicular dendritic cells in tonsils collected from PMWS-affected pigs.Porcine circovirus type 2 (PCV2) evolution before and after the vaccination introduction: A large scale epidemiological study.
P2860
Q26825289-31FB316E-3911-4424-A7AD-ECCCE2CA269CQ28308000-1FE6B8B6-7502-45B4-8DC2-CCE220BFE815Q28544473-6AD43D0F-BCD0-48AA-8A9F-6F1450B19B2EQ30425466-A7E2D039-6090-4E4E-B10E-5A54A82A92DFQ30596525-DAEED348-7FA3-4CC0-9C66-02ABE55618B7Q33407374-428FA960-EF46-4FF1-81DD-8EBEBD4FD29FQ33691634-687248C6-876D-417F-8B77-E99F04A583FCQ33786775-B8C17787-3E32-418F-A27D-DDE089A9762CQ35135318-620DC89B-E96D-4E34-9D42-16C5D669EEB5Q35142582-D0B4354A-7259-4B08-BFDE-D9D2753E91A8Q35164842-45F5B727-CB1C-43D9-98FE-3BC68244323BQ35229707-4F732140-326C-41D9-B91D-88990274D665Q35559197-11A84F6C-92EF-4BC8-9094-9CB1AFE8B593Q35603233-8ACDADCB-6A6D-4407-87AD-CB2928E140B3Q35649969-5FF6F3FD-5A9B-43B4-8BE3-F56DDBA62FACQ35899051-6EE2F731-4C18-4F45-927F-E056001961A4Q36000872-EB7C6259-241D-443A-8088-1D8736C0FB1EQ36015138-269B467E-DC04-4408-8E9D-F653AFAAD9BCQ36055659-397106A9-53DC-4ECC-B48B-E5291DD9170EQ36209712-8ED571E8-A6E3-4CA7-BC04-74212427ABD8Q36286898-07423AAE-DE39-429A-A424-860693444516Q36340432-FF872757-3D5A-4E09-8B92-812D03E7B95CQ36839251-C5CAD8CE-B262-47A3-B218-52735C6E1408Q36839257-D56AA6BB-43E4-4110-8B00-593131C5CC09Q36900388-8B955491-5733-49F7-9E42-4C143A6D59C6Q37190337-31EA9FEB-279D-4BEA-ABC9-C468DC9D9BD8Q37470430-E46BE96B-DB1E-41EA-BAAB-556E658B1F6FQ37512859-B351D46F-B697-4E2C-A480-5F4085A36F2EQ37619157-C36EF3D5-D67B-4098-A9E0-7A1C654189E3Q37694870-FFF85327-1727-4BF9-9CA3-284CBED1F288Q37720997-16217C54-2022-4025-A300-6CB2186BF293Q37723618-11B6B47A-5191-4515-97CA-BCFDA6BF430DQ38268599-F4506E8D-329A-4877-A940-77890C6804A5Q38745795-17995785-0217-4A63-B625-F47C3467BD1EQ38752018-C13726FD-51A5-479A-B4A1-76CCEFB5AA0AQ38789402-FB68BE29-6EC4-46DF-A730-D6B214A077A9Q38892874-6AD50AF2-ED8E-43B9-BCD9-80E2AABD13FAQ38903870-421AC251-2E43-4FB8-9F59-9115C914AA2BQ38993445-535F4A23-2DB2-45BA-8F4B-394C5F5B218EQ39500288-92474260-08E3-4C8A-B768-47E81FBBC308
P2860
Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Porcine circovirus type 2 (PCV ...... logy and laboratory diagnosis.
@en
Porcine circovirus type 2 (PCV ...... logy and laboratory diagnosis.
@nl
type
label
Porcine circovirus type 2 (PCV ...... logy and laboratory diagnosis.
@en
Porcine circovirus type 2 (PCV ...... logy and laboratory diagnosis.
@nl
prefLabel
Porcine circovirus type 2 (PCV ...... logy and laboratory diagnosis.
@en
Porcine circovirus type 2 (PCV ...... logy and laboratory diagnosis.
@nl
P1433
P1476
Porcine circovirus type 2 (PCV ...... ology and laboratory diagnosis
@en
P2093
Joaquim Segalés
P356
10.1016/J.VIRUSRES.2011.10.007
P577
2011-10-17T00:00:00Z